We are live on ! Find out more
TMDX icon

Transmedics

300 hedge funds and large institutions have $2.63B invested in Transmedics in 2025 Q1 according to their latest regulatory filings, with 50 funds opening new positions, 122 increasing their positions, 92 reducing their positions, and 66 closing their positions.

New
Increased
Maintained
Reduced
Closed

44% more capital inflows, than outflows

Capital inflows: $562M | Capital outflows: $391M

33% more repeat investments, than reductions

Existing positions increased: 122 | Existing positions reduced: 92

30% more call options, than puts

Call options by funds: $70.5M | Put options by funds: $54.1M

6.12% more ownership

Funds ownership: 109.9% → 116.02% (+6.1%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

5% less funds holding

Funds holding: 317 → 300 (-17)

24% less first-time investments, than exits

New positions opened: 50 | Existing positions closed: 66

Holders
300
Holders Change
-17
Holders Change %
-5.36%
% of All Funds
4.01%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
50
Increased
122
Reduced
92
Closed
66
Calls
$70.5​M
Puts
$54.1​M
Net Calls
+$16.5​M
Net Calls Change
+$27.3​M

TMDX Hedge Fund Activity: Q1 2025 in Review

300 of the 7,490 institutional investors tracked by Wall St. Rank reported a position in Transmedics (TMDX) for Q1 2025, worth a combined $2.63B — up 14% from $2.3B a quarter earlier.

Sellers outnumbered buyers: 66 funds closed out of TMDX and 50 opened new positions — a net loss of 16 holders — while 92 trimmed existing stakes and 122 added.

The largest buyer was UBS AM, adding an estimated $152M. The largest seller was Mackenzie Financial, exiting entirely with an estimated $51.6M sold.

  • 300 institutional investors held Transmedics (TMDX) as of Q1 2025, down from 317 in Q4 2024.
  • Funds reported $2.63B of Transmedics stock for Q1 2025, up 14% quarter-over-quarter.
  • 50 funds opened new Transmedics positions in Q1 2025 and 66 closed out, a net change of -16 holders.
  • The largest Transmedics buyer in Q1 2025 was UBS AM, an estimated $152M added.
  • The largest Transmedics seller in Q1 2025 was Mackenzie Financial, an estimated $51.6M sold.

Based on aggregated 13F filings for Q1 2025.